Effect of Mat Pilates Training on Women After Menopause

Sponsor
Federal University of Uberlandia (Other)
Overall Status
Completed
CT.gov ID
NCT03626792
Collaborator
(none)
50
1
2
7.7
6.5

Study Details

Study Description

Brief Summary

This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women. All volunteers received the same intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypertensive group
  • Other: Normotensive group
N/A

Detailed Description

The Pilates program was performed three times a week for 12 weeks. Initially a familiarization was made regarding the principles of the method. All volunteers underwent 24-hour blood pressure assessment using ambulatory blood pressure measurement (ABPM) and venous blood samples were collected from fasting, saliva and questionnaires before and after the Pilates training period.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Group 1 - Hypertensive: Composed of hypertensive women who participated in a training program with Pilates exercises in the soil associated to the daily antihypertensive of each one. Group 2 - Normotensives: Composed of normotensive women who participated in a training program with solo Pilates exercises without antihypertensive presence. Both groups underwent 12 weeks of Pilates training.Group 1 - Hypertensive: Composed of hypertensive women who participated in a training program with Pilates exercises in the soil associated to the daily antihypertensive of each one. Group 2 - Normotensives: Composed of normotensive women who participated in a training program with solo Pilates exercises without antihypertensive presence. Both groups underwent 12 weeks of Pilates training.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Mat Pilates Training on Climacteric Symptoms and Physiological Changes in Women After Menopause
Actual Study Start Date :
Aug 5, 2017
Actual Primary Completion Date :
Dec 20, 2017
Actual Study Completion Date :
Mar 28, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Hypertensive group

The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.

Other: Hypertensive group
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.

Other: Normotensive group

The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.

Other: Normotensive group
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.

Outcome Measures

Primary Outcome Measures

  1. Blood pressure [Change from Baseline at 12 weeks]

    Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.

Secondary Outcome Measures

  1. Ambulatory blood pressure monitoring [Change from Baseline at 12 weeks]

    Ambulatory blood pressure monitoring will be monitored during 24 hours using a Dyna+ ABPM device in mmHg.

  2. Kupperman - Blatt Index [Change from Baseline at 12 weeks]

    The climacteric symptoms will be evaluated by the following questionnaire Kupperman - Blatt Index. The questionnaire has scores that from 0 to 19 indicate mild symptoms, 20 to 35 moderate and greater than 35 symptoms of severe climacteric.

  3. Cervical Scale [Change from Baseline at 12 weeks]

    The climacteric symptoms will be evaluated by the following questionnaire Cervical Scale. The questionnaire does not have scales. Indicates only a high or low score regarding the presence of climacteric symptoms.

  4. Menopause Rating Scale (MRS) [Change from Baseline at 12 weeks]

    The climacteric symptoms will be evaluated by the following questionnaire Menopause Rating Scale (MRS). The scores from 0 to 4 of the questionnaire indicate absence of symptoms, as well as from 5 to 8 presence of mild symptoms, 9 to 15 moderate and greater than 16 symptoms of severe climacteric.

  5. Sleep quality [Change from Baseline at 12 weeks]

    Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).A score of 0 to 4 indicates a good quality of sleep, 5 to 10 quality of bad sleep and greater than 10 the presence of sleep disorder.

Other Outcome Measures

  1. Biochemical analyzes [Change from Baseline at 12 weeks]

    From the serum and/or plasma and saliva samples collected and stored, analyzes for lipid profile (total cholesterol and fractions, and triglycerides) and glycemia at rest and for the concentrations of inflammatory cytokines and changes in the activity of the Antioxidant system.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women between the ages of 40 and 70;

  • Be post menopausal (amenorrhea for at least 12 months);

  • Medical release to perform physical activities.

  • Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;

Exclusion Criteria:
  • To present a history of stroke or acute myocardial infarction;

  • Smoking;

  • Diagnosis of Diabetes Mellitus.

  • Present renal pathologies.

  • Use medications that interfere with lipid metabolism;

  • Use of antihypertensive drugs (except for the hypertensive group);

  • Use hormone replacement therapies;

  • Present gastrointestinal conditions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jaqueline Pontes Batista Uberlândia Minas Gerais Brazil 38400-678

Sponsors and Collaborators

  • Federal University of Uberlandia

Investigators

  • Study Director: Guilherme M Puga, Phd, Federal University of Uberlandia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jaqueline Pontes Batista, Principal Investigator, Federal University of Uberlandia
ClinicalTrials.gov Identifier:
NCT03626792
Other Study ID Numbers:
  • 68408116.9.0000.5152
First Posted:
Aug 13, 2018
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jaqueline Pontes Batista, Principal Investigator, Federal University of Uberlandia

Study Results

No Results Posted as of Mar 22, 2022